{
    "2020-09-25": [
        [
            {
                "time": "2020-09-25",
                "original_text": "药明康德(603259.SH)：拟将使用闲置自有资金进行现金管理的额度调整为不超86.5亿元",
                "features": {
                    "keywords": [
                        "药明康德",
                        "闲置资金",
                        "现金管理",
                        "额度调整"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-09-25",
                "original_text": "[路演]成都先导：药明康德进入DEL领域对公司影响不大",
                "features": {
                    "keywords": [
                        "药明康德",
                        "DEL领域",
                        "影响不大"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-09-25",
                "original_text": "晚间重要公告2020年9月25日星期五 药明康德(02359)拟向上海药明和香港药明进行增资",
                "features": {
                    "keywords": [
                        "药明康德",
                        "增资",
                        "上海药明",
                        "香港药明"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-09-25",
                "original_text": "北向资金连续5日净流出，新能源车产业链获外资逆势加仓",
                "features": {
                    "keywords": [
                        "北向资金",
                        "净流出",
                        "新能源车",
                        "逆势加仓"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "新能源车"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-09-25",
                "original_text": "药明康德(603259.SH)：拟向子公司上海药明增资64.57亿元向香港药明增资6亿元",
                "features": {
                    "keywords": [
                        "药明康德",
                        "子公司",
                        "增资",
                        "上海药明",
                        "香港药明"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-09-25",
                "original_text": "药明康德(603259.SH)：拟以募集资金置换预先投入的7.74亿元自筹资金",
                "features": {
                    "keywords": [
                        "药明康德",
                        "募集资金",
                        "置换",
                        "自筹资金"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-09-25",
                "original_text": "“闪崩股”频现，三因素成诱因",
                "features": {
                    "keywords": [
                        "闪崩股",
                        "诱因"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-09-25",
                "original_text": "医疗物资出口板块连续拉升，英科医疗、振德医疗、泰格医药、药明康德领涨",
                "features": {
                    "keywords": [
                        "医疗物资",
                        "出口",
                        "拉升",
                        "领涨"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-09-25",
                "original_text": "药明康德65亿定增结果出炉，CDMO为何成资本“香饽饽”？",
                "features": {
                    "keywords": [
                        "药明康德",
                        "定增",
                        "CDMO",
                        "资本"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}